KOSTKA; Marcus

Patent Applications and Registrations

Patent applications and USPTO patent grants for KOSTKA; Marcus.The latest application filed is for "new virus particles for therapeutic purposes".

Company Profile

0.5.16

KOSTKA; Marcus - Dusseldorf DE
KOSTKA; Marcus - Biberach DE
Kostka, Marcus - Mainz DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
New Virus Particles For Therapeutic Purposes App 20220273741 - VOLLMER; Jorg ; et al.	2022-09-01
Substituted 1,2-ethylenediamines, Methods For Preparing Them And Uses Thereof App 20100204160 - EICKMEIER; Christian ; et al.	2010-08-12
Substituted 1,2-ethylenediamines, methods for preparing them and uses thereof Grant 7,713,961 - Eickmeier , et al. May 11, 2	2010-05-11
Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof App 20090325940 - Eickmeier; Christian ; et al.	2009-12-31
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds Grant 7,534,787 - Bornemann , et al. May 19, 2	2009-05-19
Method of Treating Diseases and Conditions Associated with an Altered Level of Amyloid Beta Peptides and New Enolcarboxamide Compounds App 20090099159 - BORNEMANN; Klaus ; et al.	2009-04-16
Substituted Ethane-1,2-Diamines for the Treatment of Alzheimer's Disease II App 20080293680 - Peters; Stefan ; et al.	2008-11-27
Method of treating diseases and conditions associated with an altered level of amyloid .beta. peptides and new enolcarboxamide compounds Grant 7,393,843 - Bornemann , et al. July 1, 2	2008-07-01
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds App 20080139541 - Bornemann; Klaus ; et al.	2008-06-12
Method of treating diseases and conditions associated with an altered level of amyloid .beta. peptides and new enolcarboxamide compounds Grant 7,375,220 - Bornemann , et al. May 20, 2	2008-05-20
Statine derivatives for the treatment of Alzheimer's disease III Grant 7,238,774 - Peters , et al. July 3, 2	2007-07-03
Substituted 1,2-ethylenediamines, Methods for Preparing Them and Uses Thereof App 20060223759 - Eickmeier; Christian ; et al.	2006-10-05
Statine derivatives for the treatment of Alzheimer's disease II App 20060160747 - Peters; Stefan ; et al.	2006-07-20
Statine derivatives for the treatment of Alzheimer's disease III App 20060100158 - Peters; Stefan ; et al.	2006-05-11
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds App 20060040928 - Bornemann; Klaus ; et al.	2006-02-23
Substituted ethane-1,2-diamines for the treatment of Alzheimer's disease App 20060025345 - Peters; Stefan ; et al.	2006-02-02
Method of treating diseases and conditions associated with an altered level of amyloid beta peptides and new enolcarboxamide compounds App 20050277635 - Bornemann, Klaus ; et al.	2005-12-15
Novel statine derivatives for the treatment of Alzheimer's disease App 20050090449 - Fuchs, Klaus ; et al.	2005-04-28
Gamma-secretase in vitro screening assay App 20030022251 - Fuchs, Klaus ; et al.	2003-01-30
Process for finding a protease inhibitor App 20020025508 - Fechteler, Katja ; et al.	2002-02-28
Aspartylprotease App 20020016296 - Haass, Christian ; et al.	2002-02-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.